U.S. Markets close in 4 hrs 12 mins

Critical Outcome Technologies Inc. (COT.V)


TSXV - TSXV Delayed Price. Currency in CAD
Add to watchlist
1.570.00 (0.00%)
As of 9:45AM EDT. Market open.
People also watch
IMM.VDMA.VCZO.VCOV.VELEZF

Critical Outcome Technologies Inc.

700 Collip Circle
Suite 213
London, ON N6G 4X8
Canada
519-858-5157
http://www.criticaloutcome.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees

Key Executives

NameTitlePayExercisedAge
Ms. Alison Silva MA, MSChief Exec. Officer, Pres and Director68.76kN/AN/A
Mr. Eugene Francis KellyChief Financial OfficerN/AN/AN/A
Ms. Debi Sanderson MBADirector of Resourcing & OperationsN/AN/AN/A
Dr. Richard T. Ho M.D., Ph.D.Chief Scientific OfficerN/AN/A54
Mr. Paul PapiVP of Investor RelationsN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Critical Outcome Technologies Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of cancer in Canada. The company’s proprietary artificial intelligence platform, CHEMSAS, utilizes a series of predictive computer models to identify compounds from disease specific drug discovery through chemical optimization and preclinical testing. Its lead compound is COTI-2, a novel small molecule activator of misfolded mutant p53 proteins, which is in Phase I clinical trial for the treatment of gynecologic cancers, including ovarian, cervical, and endometrial cancers. The company also develops drug candidates for the treatment of acute myelogenous leukemia, colorectal cancer, small cell lung cancer, multiple sclerosis, and Alzheimer’s disease; and HIV integrase inhibitors. Critical Outcome Technologies Inc. was founded in 1999 and is based in London, Canada.

Corporate Governance

Critical Outcome Technologies Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.